Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiepifengdou granules is a Traditional Chinese Medicine (TCM) botanical product primarily composed of extracts from *Dendrobium officinale* (known as Tiepishihe). Developed by Zhejiang Tianhuang Pharmaceutical, it is designed to treat chronic atrophic gastritis, particularly in patients presenting with the 'Qi-Yin deficiency' pattern. The therapeutic is believed to nourish Yin, clear heat, and benefit the stomach, thereby promoting the repair of the gastric mucosa and alleviating symptoms such as epigastric pain, bloating, and dryness. It has been studied in Phase 2 clinical trials in China to evaluate its efficacy and safety in improving gastric mucosal atrophy and intestinal metaplasia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tiepifengdou granules (Zhejiang Tianhuang Technology Industry).